Get started
Author

M. V. Zlobin

Observed names: M.V. Zlobin, M.V. Zlobin Zlobin, Злобин М. В., М. В. Злобин
ORCID: 0000-0002-8200-3293
Observed ORCID: 0000-0002-8200-3293
OpenAlex ID: A5073774551
Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register
2023 · E. A. Belousova, Yu. A. Shelygin, et al. · Koloproktologia · 35
PDF
Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence
2025 · P. A. Shesternya, A. I. Zagrebneva, et al. · Modern Rheumatology Journal · 5
PDF
The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Doklady Biochemistry and Biophysics · 3
PDF
Direct interleukin-6 blockade in real-world clinical practice – a path to rationalization of pharmacotherapy and control of rheumatoid arthritis
2026 · P. A. Shesternya, E. M. Aitova, et al. · Modern Rheumatology Journal · 2
PDF
Efficacy of a modern treat-to-target strategy in patients with Crohn’s disease: Results of a 52-week clinical observation
2026 · M.V. Zlobin Zlobin, D.I. Abdulganieva Abdulganieva, et al. · Therapy
Assessment of the prevalence of systemic lupus erythematosus in women with reproductive health problems in the Russian Federation. Results of the multicenter pilot PRISMA study
2026 · T. M. Reshetnyak, E. A. Trofimov, et al. · Modern Rheumatology Journal
PDF
Case of ANCA-associated vasculitis debuted with clinical picture of severe community-acquired pneumonia
2025 · S.Yu. Chikina, D.I. Nikolaichuk, et al. · Journal of Respiratory Medicine
Extract of oak bark as a selective natural reagent for the spectrophotometric determination of iron (II) in pharmaceutical preparations and blood serum
2025 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice
Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Modern Rheumatology Journal
PDF
Impact of baseline metabolic abnormalities on clinical outcomes in patients with COVID-19
2025 · A.Yu. Yakovlev, A.A. Pevnev, et al. · Infekcionnye bolezni
Socio-demographic characteristics, features of the course and treatment of ulcerative colitis in the Nizhny Novgorod region
2023 · M. V. Zlobin, A. A. Alekseeva, et al. · Экспериментальная и клиническая гастроэнтерология
PDF
Распространенность коморбидной патологии у пациентов с воспалительными заболеваниями кишечника
· М. В. Злобин, Д. И. Абдулганиева, et al. · CyberLeninK (CyberLeninka)
Применение прямого ингибитора интерлейкина 6 олокизумаба в терапии ревматоидного артрита: данные реальной клинической практики
· Шестерня П. А., Загребнева А. И., et al. · CyberLeninK (CyberLeninka)
Эффективность и безопасность левилимаба при внутривенном и подкожном введении пациентам с активным ревматоидным артритом: результаты рандомизированного сравнительного двойного слепого контролируемого клинического исследования III фазы LUNAR
· В. И. Мазуров, А. М. Лила, et al. · CyberLeninK (CyberLeninka)
Works count: 14
Citation count: 45
H-index: 3
I10-index: 1
Year
Topic
Type